Skip links and keyboard navigation

PAH Urologic Oncologist awarded

9 June 2017

Dr Ian Vela - PAH Urologic Oncologist awardedPrincess Alexandra Hospital's Urologic Oncologist Dr Ian Vela has been recognised for his cutting-edge prostate cancer research by the Australian Society for Medical Research (ASMR) and Queensland Health.

Dr Vela was awarded the 2017 Clinical Researcher Award for his Precision Medicine project at PAH, which aimed to improve patient outcomes in all stages of prostate cancer through the use of the latest technological developments.

“Precision medicine is all about making sure the right patient is treated with the right treatment at the right time. It’s individualised medicine,” he said.

“My team is using the precision medicine philosophy for all the stages of prostate cancer– from diagnosis, to treatment of localised disease, through to treatment of advanced disease as an integrated program.”

Dr Vela said the research would allow health professionals to identify how cancer spreads through the body, the early and reoccurring stages of prostate cancer, and to ultimately improve the outcome of the disease in men.

“Through a variety of cutting edge programs including molecular imaging and genetic analyses, my team aims to provide the best precision medicine to the men of Queensland with prostate cancer,” he said.

Dr Vela was thrilled to receive the award but said he was accepting on behalf of his whole team.

“Our project, the work we are doing and the successes we have had to-date, have all been made possible due to the dedication and skill of the entire team,” he said.

“Everyone involved from a clinical and non-clinical level have dedicated themselves 100 per cent because they know how much of an impact our work will have on the lives of men.”

With Men’s Health Week next week (Monday 12 June to Sunday 18 June), men are reminded and encouraged to visit their GP for their annual check-up.

Last updated 15 June 2017
Last reviewed 9 June 2017

Other news

Bowel cancer early detection is key

Bowel Cancer—early detection is key

Bowel cancer is Australia’s second biggest cancer killer but is one of the most treatable types if found early. This Bowel Cancer Awareness Month Princess Alexandra Hospital Health Promotion Officer Abby Fraser was encouraging the community to ‘Make No. 2 your No. 1 priority’ and participate in the free National Bowel Cancer Screening Program.

Dr Darshan Shah clot dissolving drug trial for stroke patients

Trial tests time-saving clot-dissolving drug

A clot-dissolving drug trial could see stroke patients receive life-saving treatment faster. The Princess Alexandra Hospital Stroke Unit was participating in a trial that aimed to show Tenecteplase, a clot-dissolving drug currently used in heart attack patients, could reduce treatment time for stroke patients by an hour.